Core Viewpoint - Rosen Law Firm is reminding investors who purchased F5, Inc. securities between October 28, 2024, and October 27, 2025, of the February 17, 2026, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought F5 securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by February 17, 2026, to serve as lead plaintiff [2]. - The lawsuit alleges that F5 misrepresented its revenue outlook and growth potential while downplaying risks associated with seasonality and macroeconomic factors [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company and has been ranked highly for its performance in securities class action settlements [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Gauzy Ltd. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Gauzy securities between March 11, 2025, and November 13, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 6, 2026 [3] - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [4] Group 3: Case Allegations - The lawsuit alleges that Gauzy's defendants made false or misleading statements regarding the financial stability of three French subsidiaries, which were likely to face insolvency proceedings [5] - It is claimed that these misleading statements resulted in a potential default under Gauzy's existing senior secured debt facilities [5] - The lawsuit asserts that when the true financial situation was revealed, investors suffered damages due to the misleading information provided by the defendants [5]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of common stock of Vistagen Therapeutics, Inc. for the period between April 1, 2024, and December 16, 2025, due to alleged misleading statements regarding the company's drug fasedienol [1][5][6]. Group 1: Lawsuit Details - The lawsuit claims that Vistagen provided investors with overly positive information about the development and commercialization of fasedienol, an investigational drug for social anxiety disorder, while concealing material adverse facts about its Phase 3 PALISADE-3 trial [5][6]. - Investors are alleged to have purchased Vistagen common stock at artificially inflated prices due to these misleading statements, resulting in damages when the true information became public [6]. Group 2: Class Action Participation - Investors who purchased Vistagen Therapeutics common stock during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm directly for more information [3][7]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is reminding former stockholders of Smartsheet Inc. about a class action lawsuit related to the January 2025 sale of Smartsheet to a consortium including Blackstone, Vista Equity Partners, and Platinum Falcon, with a lead plaintiff deadline set for February 24, 2026 [1]. Group 1: Class Action Details - Former Smartsheet stockholders may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 24, 2026 [3]. - The complaint alleges that Smartsheet's solicitation of stockholder approval for the Buyout involved a false and misleading Proxy statement that mischaracterized the company's financial performance [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its success in securities class action settlements [4].

NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Bath & Body Works, Inc. (NYSE: BBWI) securities between June 4, 2024 and November 19, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 16, 2026. SO WHAT: If you purchased Bath & Body Works securities during the Class Per ...

New York, New York--(Newsfile Corp. - January 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Coupang, Inc. (NYSE: CPNG) between August 6, 2025 and December 16, 2025, both dates inclusive (the "Class Period"), of the important February 17, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.SO WHAT: If you purchased Coupang securities during the Class Period you may be entitled to compensation without payment of any out ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for alleged misrepresentations regarding its accounts receivable during the Class Period from July 18, 2024, to November 12, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Ardent Health made false statements about its accounts receivable management, including the reliance on "detailed reviews of historical collections" and the adequacy of its professional malpractice liability insurance [5]. - It is alleged that Ardent Health did not accurately assess the collectability of its accounts receivable, using a 180-day cliff method that inflated reported amounts and delayed loss recognition [5]. - The lawsuit indicates that when issues with claim denials arose, Ardent Health downplayed the situation and failed to write off uncollectible accounts, leading to investor damages when the truth was revealed [5]. Group 2: Class Action Participation - Investors who purchased Ardent Health securities during the Class Period may be eligible for compensation without upfront costs through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm for more information [3][6]. - A lead plaintiff must be appointed by March 9, 2026, to represent the class in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with notable achievements in previous years, including over $438 million in 2019 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Blue Owl Capital Inc. during the specified class period of the upcoming lead plaintiff deadline, indicating potential compensation opportunities for affected investors [1]. Group 1: Class Action Details - The class action lawsuit against Blue Owl Capital Inc. has been filed, and investors who wish to serve as lead plaintiff must act by February 2, 2026 [2]. - Investors can join the class action without incurring out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [3]. Group 3: Case Allegations - The lawsuit alleges that Blue Owl made false or misleading statements regarding its asset base and liquidity issues, which were not disclosed to investors [4]. - It is claimed that these misrepresentations led to significant investor damages when the true situation was revealed [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Coupang, Inc. securities between August 6, 2025, and December 16, 2025, of the upcoming lead plaintiff deadline for a securities class action lawsuit set for February 17, 2026 [1]. Group 1: Class Action Details - Investors who bought Coupang securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must file with the Court by February 17, 2026 [3]. - The lawsuit alleges that Coupang made false and misleading statements regarding its cybersecurity protocols, which allowed unauthorized access to sensitive customer information for nearly six months [5]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [4]. - The firm has been recognized for its leadership in securities class action settlements, achieving the largest settlement against a Chinese company at the time and ranking highly in securities class action settlements since 2013 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of StubHub Holdings, Inc. about the upcoming lead plaintiff deadline for a class action lawsuit related to the company's September 2025 IPO [1]. Group 1: Class Action Details - Investors who purchased StubHub common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 23, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that the Registration Statement issued during the IPO was materially false and misleading, omitting critical information about changes in payment timing to vendors and their adverse impact on free cash flow [5]. - It is claimed that these omissions led to misleading reports on StubHub's free cash flow and that positive statements made by the defendants regarding the company's business and prospects lacked a reasonable basis [5].